Published in Ann Rheum Dis on January 01, 1987
Organising pneumonia. Thorax (2000) 2.51
Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009. Clin Rheumatol (2010) 0.88
Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol (2002) 0.85
Polymyositis/dermatomyositis: the current position. Ann Rheum Dis (1991) 0.85
Inflammatory myopathy, bronchiolitis obliterans/organizing pneumonia, and anti-Jo-1 antibodies--an interesting association. Clin Diagn Lab Immunol (1997) 0.81
Polymyositis-dermatomyositis: a clinical review. Postgrad Med J (1989) 0.79
HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients. Clin Rheumatol (2015) 0.78
Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature. Medicine (Baltimore) (2016) 0.75
Deviation in the recovery of the lower limb and respiratory muscles of patients with polymyositis: a preliminary clinical study. J Phys Ther Sci (2016) 0.75
Role of Microbial Agents in Pulmonary Fibrosis . Yale J Biol Med (2017) 0.75
Polymyositis and dermatomyositis (first of two parts). N Engl J Med (1975) 18.52
Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) (1977) 4.79
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med (1984) 3.73
Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med (1981) 3.08
Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis (1979) 2.31
Intraluminal fibrosis in interstitial lung disorders. Am J Pathol (1986) 2.10
Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc (1986) 1.68
Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum (1979) 1.47
Interstitial pneumonitis in dermatomyositis. J Am Med Assoc (1956) 1.32
Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol (1984) 1.30
Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum (1984) 1.24
Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) (1976) 1.24
Polymyositis and diffuse interstitial lung disease. A review of the pulmonary histopathologic findings. Arch Intern Med (1981) 1.12
Pulmonary vascular changes in scleroderma. Am J Med (1978) 1.04
Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases. Am J Med (1974) 1.03
Interstitial lung disease in polymyositis and dermatomyositis. J Rheumatol (1980) 0.96
THREE TYPES OF PULMONARY INVOLVEMENT IN POLYMYOSITIS. Med Clin North Am (1964) 0.96
Pulmonary involvement in polymyositis: report of a case with response to corticosteroid therapy. Arthritis Rheum (1968) 0.92
Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma. Ann Rheum Dis (1981) 0.89
Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases. Clin Exp Immunol (1984) 0.85
Pulmonary hypertension in polymyositis. Chest (1981) 0.84
Pulmonary fibrosis masking polymyositis. Remission with corticosteroid therapy. JAMA (1972) 0.80
Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28
Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum (1990) 8.92
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum (1990) 8.67
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum (1990) 8.36
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum (1990) 8.23
Clinical utility of thoracoscopy. Chest (1992) 6.34
Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45
Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27
Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22
The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum (1990) 5.09
Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc (1978) 4.92
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum (1990) 4.43
Microwave oven for melting laboratory media. J Clin Microbiol (1978) 4.33
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28
Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol (1971) 3.60
Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc (1974) 3.54
Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52
Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36
The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med (1992) 3.36
Causes of death in patients with tuberous sclerosis. Mayo Clin Proc (1991) 3.18
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14
Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11
Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol (1976) 3.09
Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med (1978) 2.99
Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A (1970) 2.89
Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc (1981) 2.88
Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87
Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86
Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85
In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82
Classification of ventricular septal defects. Br Heart J (1980) 2.79
Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) (1985) 2.78
Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol (1975) 2.76
Cardiac myxomas: a clinicopathologic profile. Am J Pathol (1980) 2.74
Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol (1971) 2.60
New histochemical method for morphologic diagnosis of early stages of myocardial ischemia. Mayo Clin Proc (1971) 2.58
Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome. Mayo Clin Proc (1973) 2.56
API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol (1979) 2.54
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53
Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51
Prevalence of serotypes of Salmonella. Appl Microbiol (1969) 2.50
Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48
Diverticula of the Small Bowel. Ann Surg (1934) 2.44
Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37
Bacteroides bacteremia. Minn Med (1970) 2.36
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum (1990) 2.32
Atrial myxomas: a review of clinical experience in 40 patients. Mayo Clin Proc (1980) 2.26
Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26
Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1980) 2.26
Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23
Vasculitis in the central nervous system. Arthritis Rheum (1997) 2.20
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12
Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06
Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res (1988) 2.06
Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol (1986) 2.05
Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc (1980) 2.04
Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1979) 2.04
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum (1990) 2.02
Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc (1983) 2.01
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med (1977) 1.97
Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol (1981) 1.94
Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs. J Exp Med (1970) 1.90
Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90
Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol (1971) 1.87
Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res (1991) 1.86
Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol (1985) 1.85
Nonsystemic vasculitic neuropathy. Brain (1987) 1.84
Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol (1973) 1.83
Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol (1991) 1.82
Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA (1970) 1.80
Carcinoembryonic antigenic activity of tissue extracts: a quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs. Int J Cancer (1973) 1.76
In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc (1970) 1.72
Cell-adhesive motif in region II of malarial circumsporozoite protein. Science (1990) 1.69
Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc (1986) 1.68
An analgesia circuit activated by cannabinoids. Nature (1998) 1.68
Anti-Salmonella agglutinins in chronic active liver disease. Lancet (1971) 1.67
Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation (1982) 1.64
Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63
Diagnostic value and limitations of orbital biopsy in Wegener's granulomatosis. Ophthalmology (1992) 1.62
In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.60
Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum (1972) 1.56
How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med (1994) 1.55
Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci U S A (1971) 1.55
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53
Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53
In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc (1970) 1.53
Aortitis syndrome (Takayasu's arteritis) associated with systemic lupus erythematosus. J Rheumatol (1989) 1.52
Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria. Am J Clin Pathol (1974) 1.52
Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria). Mayo Clin Proc (1972) 1.52
Site of action of antilymphocyte globulin. Lancet (1967) 1.51
Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis (1984) 1.50